BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27098984)

  • 1. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.
    Mifsud MJ; Tanvetyanon T; Mccaffrey JC; Otto KJ; Padhya TA; Kish J; Trotti AM; Harrison LB; Caudell JJ
    Head Neck; 2016 Nov; 38(11):1628-1633. PubMed ID: 27098984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
    Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
    Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.
    Gebhardt BJ; Ohr JP; Ferris RL; Duvvuri U; Kim S; Johnson JT; Heron DE; Clump DA
    Am J Clin Oncol; 2018 Sep; 41(9):888-893. PubMed ID: 28394767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Therapy for Salivary Gland Carcinomas.
    Sayan M; Vempati P; Miles B; Teng M; Genden E; Demicco EG; Misiukiewicz K; Posner M; Gupta V; Bakst RL
    Anticancer Res; 2016 Aug; 36(8):4165-70. PubMed ID: 27466526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of patients with malignant salivary gland tumors.
    Bell RB; Dierks EJ; Homer L; Potter BE
    J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
    Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
    Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
    Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B
    Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymph node density in high-grade salivary gland cancers.
    Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
    Chen MM; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer.
    Jang JY; Choi N; Ko YH; Chung MK; Son YI; Baek CH; Baek KH; Jeong HS
    BMC Cancer; 2018 Jun; 18(1):672. PubMed ID: 29925355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.
    Scherl C; Haderlein M; Agaimy A; Mantsopoulos K; Koch M; Traxdorf M; Fietkau R; Grundtner P; Iro H
    Strahlenther Onkol; 2019 Dec; 195(12):1050-1059. PubMed ID: 31350567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Resection Improves Overall Survival in cT4b Major Salivary Gland Cancer.
    Patel AM; Haleem A; Choudhry HS; Brant JA; Brody RM; Carey RM
    Otolaryngol Head Neck Surg; 2024 May; 170(5):1349-1363. PubMed ID: 38426575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
    Tanvetyanon T; Qin D; Padhya T; McCaffrey J; Zhu W; Boulware D; DeConti R; Trotti A
    Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
    Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer.
    Hanson M; McGill M; Mimica X; Eagan A; Hay A; Wu J; Cohen MA; Patel SG; Ganly I
    JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):128-138. PubMed ID: 34854898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative.
    Morand GB; Eskander A; Fu R; de Almeida J; Goldstein D; Noroozi H; Hosni A; Seikaly H; Tabet P; Pyne JM; Matthews TW; Dort J; Nakoneshny S; Christopoulos A; Bahig H; Johnson-Obaseki S; Hua N; Gaudet M; Jooya A; Nichols A; Laxague F; Cecchini M; Du J; Shapiro J; Karam I; Dziegielewski PT; Hanubal K; Erovic B; Grasl S; Davies J; Monteiro E; Gete M; Witterick I; Sadeghi N; Richardson K; Shenouda G; Maniakas A; Landry V; Gupta M; Zhou K; Mlynarek AM; Pusztaszeri M; Sultanem K; Hier MP
    Cancer; 2023 Oct; 129(20):3263-3274. PubMed ID: 37401841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.